<scp>CGM</scp> ‐derived average glucose is more strongly associated with microvascular complications than <scp>HbA1c</scp> in type 1 diabetes
CGM-derived average glucose appears superior to HbA1c as a marker of prevalent microvascular complications. These data challenge the high-glycator hypothesis and also suggest glucose variability may be an independent risk marker for microvascular disease.
Authors
- Fraser W. Gibb (ORCID: https://orcid.org/0000-0002-5576-6463)
- Shareen Forbes (ORCID: https://orcid.org/0000-0002-9127-0641)
- Roland H. Stimson (ORCID: https://orcid.org/0000-0002-9002-6188)
- Mark W. J. Strachan (ORCID: https://orcid.org/0000-0003-2628-1202)
- Anna R. Dover
- Marcus J. Lyall (ORCID: https://orcid.org/0000-0002-2952-2676)
- Michael S. Crane
- Rohana J. Wright
Institutions
- NHS Lothian (GB)
- The Queen's Medical Research Institute (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1111/dom.70365
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Dexcom
- Abbott Diabetes Care